Affiliation:
1. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, People’s Republic of China.
2. University of Chinese Academy of Sciences, Beijing 100049, People’s Republic of China.
Abstract
Self-assembly of CA inhibitor offers strategic therapy for hypoxic tumors, with marked selectivity and interesting mode of action.
Funder
National Natural Science Foundation of China
National Basic Research Program of China
The National Science Fund for Excellent Young Scholars
The National Science Fund for Distinguished Young Scholars
Science Fund for Creative Research Groups of the National Natural Science Foundation of China
CAS Key Research Program for Frontier Sciences
Key Program for International S&T Cooperation Projects of China
Bureau of International Co-operation Chinese Academy of Sciences
Publisher
American Association for the Advancement of Science (AAAS)
Reference43 articles.
1. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy;Brown J. M.;Cancer Res.,1998
2. The hypoxic tumour microenvironment and metastatic progression;Subarsky P.;Clin. Exp. Metastasis,2003
3. Mechanical approaches to oncological drug delivery;Carlisle R.;Ther. Deliv.,2013
4. Targeting hypoxia in cancer therapy
5. Carbonic anhydrase IX inhibitors in cancer therapy: An update;Supuran C. T.;Future Med. Chem.,2015
Cited by
121 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献